-
Selgantolimod
- names:
Selgantolimod
- CAS号:
2004677-13-6
MDL Number: - MF(分子式): C14H20FN5O MW(分子量): 293.34
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM004665-5mg | 5mg | ¥ 0.00 | ¥ 0.00 | Backorder | ¥ 0.00 | |||
| YZM004665-1mg | 1mg | >97% | ¥ 0.00 | ¥ 0.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | Selgantolimod |
| CAS号 | 2004677-13-6 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C14H20FN5O |
| 分子量 Molecular Weight | 293.34 |
| 溶解度Solubility | |
| 性状 | |
| 储藏条件 Storage conditions | 请根据产品建议的存储条件进行存储,Please store the product under the recommended condition sin the description. |
| 产品说明 | |
| Introduction | Selgantolimod is an orally active, potent and selectivetollike receptor 8 (TLR8)agonist for the treatment of hepatitis B virus (HBV) and human immunodeficiency virus (HIV) infection[2][3]. |
| Application1 | |
| Application2 | |
| Application3 |
Selgantolimod 是一种有效的口服活性,有效和选择性的 Toll 样受体 8 (TLR8) 激动剂,用于治疗乙型肝炎病毒和 HIV 感染。Selgantolimod is an orally active, potent and selectivetoll-like receptor 8 (TLR8)agonist for the treatment of hepatitis B virus (HBV) and human immunodeficiency virus (HIV) infection[1][2][3].
【1】.Jules Levin. Efficacy and Safety of Oral TLR8 Agonist Selgantolimod in Virally Suppressed Adult Patients With Chronic Hepatitis B: a Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study. 2019 Nov 8-12.
【2】.Benjamin Ryan. Selgantolimod Shows Promise as Treatment for Hepatitis B. November 18, 2019.
【3】.Romas Geleziunas, et al. Modulators of toll-like receptors for the treatment of hiv. US20170071944A1.
【2】.Benjamin Ryan. Selgantolimod Shows Promise as Treatment for Hepatitis B. November 18, 2019.
【3】.Romas Geleziunas, et al. Modulators of toll-like receptors for the treatment of hiv. US20170071944A1.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


